 AIkido Pharma Inc. Nasdaq: AIKI AIkido or the Company today announced that on July 31, 2020, the Company received a letter from the Listing Qualifications Department of The NASDAQ Stock Market indicating that it has regained compliance with the 1.00 minimum bid price requirement for continued listing on The NASDAQ Capital Market under Listing Rule 5550a2. The Company regained compliance with the NASDAQs requirements when the closing bid price for the Companys common stock was at or above 1.00 for ten consecutive business days. 